Global consulting giant McKinsey & Company is close to finalizing a $600 million settlement with the United States government ...

McKinsey & Co is in the final stages of negotiating a deferred prosecution agreement to resolve a U.S. criminal investigation ...

McKinsey is close to paying more than $600mn to settle a criminal investigation into its work advising US opioid manufacturers on how to boost sales, following claims it fuelled the country’s ...

The settlement, expected to be unveiled before ... fuel the opioid epidemic through its work advising OxyContin maker Purdue Pharma and other drugmakers. The settlements involved all 50 states ...

Spirit Airlines continues 'constructive talks' with creditors | Reuters - On Tuesday, ultra-low-cost carrier Spirit Airlines ...

Last week, a… A landmark settlement in the nation's opioid epidemic is forcing the owners of OxyContin maker Purdue Pharma to give up the company and pay out $4.5 billion. But many families of ...

The telegenic lawyer served on Trump’s defense team in his first Senate impeachment trial in 2020 for pressuring Ukraine to ...

A judge in the US has approved the sale of Purdue Pharma’s consumer health business Avrio, part of the bankruptcy proceedings related to the drugmaker’s proposed $10 billion settlement of ...

Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...

Buprenorphine is the best tool doctors have for patients trying to end dependency on drugs like fentanyl and OxyContin.